Evidence map›Paper›PMID 38027511›Full record

ReviewFrontiers in neuroscience2023

Enteric glia as a player of gut-brain interactions during Parkinson's disease.

Beatriz Thomasi, Luisa Valdetaro, Maria Carolina Ricciardi, Marianna Gonçalves de Carvalho, Isabela Fialho Tavares, Ana Lucia Tavares-Gomes

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Enteric glia, neuropeptides, and Parkinson's: impacts of calcitonin gene-related peptide on gut alpha synuclein.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Beatriz ThomasiDepartment of Physiology, Michigan State University, East Lansing, MI, United States.
Luisa ValdetaroDepartment of Molecular Pathobiology, NYU College of Dentistry, New York, NY, United States.
Maria Carolina RicciardiNeuroglial Interaction Lab, Neuroscience Program, Universidade Federal Fluminense, Niterói, Brazil.
Marianna Gonçalves de CarvalhoNeuroglial Interaction Lab, Neurobiology Department, Universidade Federal Fluminense, Niterói, Brazil.
Isabela Fialho TavaresNeuroglial Interaction Lab, Neurobiology Department, Universidade Federal Fluminense, Niterói, Brazil.
Ana Lucia Tavares-GomesNeuroglial Interaction Lab, Neuroscience Program, Universidade Federal Fluminense, Niterói, Brazil.
Universidade Federal Fluminense · BRMichigan State University · USNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The enteric glia has been shown as a potential component of neuroimmune interactions that signal in the gut-brain axis during Parkinson's disease (PD). Enteric glia are a peripheral glial type found in the enteric nervous system (ENS) that, associated with enteric neurons, command various gastrointestinal (GI) functions. They are a unique cell type, with distinct phenotypes and distribution in the gut layers, which establish relevant neuroimmune modulation and regulate neuronal function. Comprehension of enteric glial roles during prodromal and symptomatic phases of PD should be a priority in neurogastroenterology research, as the reactive enteric glial profile, gastrointestinal dysfunction, and colonic inflammation have been verified during the prodromal phase of PD-a moment that may be interesting for interventions. In this review, we explore the mechanisms that should govern enteric glial signaling through the gut-brain axis to understand pathological events and verify the possible windows and pathways for therapeutic intervention. Enteric glia directly modulate several functional aspects of the intestine, such as motility, visceral sensory signaling, and immune polarization, key GI processes found deregulated in patients with PD. The search for glial biomarkers, the investigation of temporal-spatial events involving glial reactivity/signaling, and the proposal of enteric glia-based therapies are clearly demanded for innovative and intestine-related management of PD.

Indexed as

enteric gliagut-brain axisneuroglial signalingneuroinflammationParkinson’s disease

Identifiers

PMID38027511
PMCPMC10644407
OpenAlexW4388075265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.